209 related articles for article (PubMed ID: 26243307)
1. Role of sphingomyelinases in neurological disorders.
Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
[TBL] [Abstract][Full Text] [Related]
3. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway.
Malaplate-Armand C; Florent-Béchard S; Youssef I; Koziel V; Sponne I; Kriem B; Leininger-Muller B; Olivier JL; Oster T; Pillot T
Neurobiol Dis; 2006 Jul; 23(1):178-89. PubMed ID: 16626961
[TBL] [Abstract][Full Text] [Related]
4. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
5. Bacterial infections and ceramide.
Grassmé H; Becker KA
Handb Exp Pharmacol; 2013; (216):305-20. PubMed ID: 23563663
[TBL] [Abstract][Full Text] [Related]
6. Ceramide and sphingomyelinases in the regulation of stress responses.
Sawai H; Hannun YA
Chem Phys Lipids; 1999 Nov; 102(1-2):141-7. PubMed ID: 11001568
[TBL] [Abstract][Full Text] [Related]
7. The roles of neutral sphingomyelinases in neurological pathologies.
Horres CR; Hannun YA
Neurochem Res; 2012 Jun; 37(6):1137-49. PubMed ID: 22237969
[TBL] [Abstract][Full Text] [Related]
8. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
9. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
[TBL] [Abstract][Full Text] [Related]
10. Signalling sphingomyelinases: which, where, how and why?
Levade T; Jaffrézou JP
Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
12. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
Jana A; Pahan K
J Biol Chem; 2004 Dec; 279(49):51451-9. PubMed ID: 15452132
[TBL] [Abstract][Full Text] [Related]
13. An acidic sphingomyelinase Type C activity from Mycobacterium tuberculosis.
Castro-Garza J; González-Salazar F; Quinn FD; Karls RK; De La Garza-Salinas LH; Guzmán-de la Garza FJ; Vargas-Villarreal J
Rev Argent Microbiol; 2016; 48(1):21-6. PubMed ID: 26948102
[TBL] [Abstract][Full Text] [Related]
14. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
15. Acid and neutral sphingomyelinases: roles and mechanisms of regulation.
Marchesini N; Hannun YA
Biochem Cell Biol; 2004 Feb; 82(1):27-44. PubMed ID: 15052326
[TBL] [Abstract][Full Text] [Related]
16. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
17. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
[TBL] [Abstract][Full Text] [Related]
18. The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends.
Mir IH; Thirunavukkarasu C
Arch Toxicol; 2023 Aug; 97(8):2069-2087. PubMed ID: 37248308
[TBL] [Abstract][Full Text] [Related]
19. Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.
Mikati MA; Zeinieh M; Habib RA; El Hokayem J; Rahmeh A; El Sabban M; Usta J; Dbaibo G
Epilepsy Res; 2008 Oct; 81(2-3):161-6. PubMed ID: 18603412
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ceramide system in cancer.
Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
